The eight main blood types are A+, A-, B+, B-, O+, O-, AB+, and AB-. The most common blood type in the United States is O-positive, with around 38 percent of the population having this type of blood. However, blood type O-positive is more common in Latino-Americans than other ethnicities, with around 53 percent of Latino-Americans with this blood type, compared to 47 percent of African Americans and 37 percent of Caucasians. Blood donation The American Red Cross estimates that every two seconds someone in the United States needs blood or platelets, highlighting the importance of blood donation. It was estimated that in 2021, around 6.5 million people in the U.S. donated blood, with around 1.7 million of these people donating for the first time. Those with blood type O-negative are universal blood donors, meaning their blood can be transfused for any blood type. Therefore, this blood type is the most requested by hospitals. However, only about seven percent of the U.S. population has this blood type. Blood transfusion Blood transfusion is a routine procedure that involves adding donated blood to a patient’s body. There are many reasons why a patient may need a blood transfusion, including surgery, cancer treatment, severe injury, or chronic illness. In 2021, there were around 10.76 million blood transfusions in the United States. Most blood transfusions in the United States occur in an inpatient medicine setting, while critical care accounts for the second highest number of transfusions.

The most common blood type among the population in the United States is O-positive. Around 53 percent of the Latino-American population in the U.S. has blood type O-positive, while only around 37 percent of the Caucasian population has this blood type. The second most common blood type in the United States is A-positive. Around 33 percent of the Caucasian population in the United States has A-positive blood type. Blood type O-negative Those with blood type O-negative are universal donors as this type of blood can be used in transfusions for any blood type. O-negative blood type is most common in the U.S. among Caucasian adults. Around eight percent of the Caucasian population has type O-negative blood, while only around one percent of the Asian population has this blood type. Only around seven percent of all adults in the United States have O-negative blood type. Blood Donations The American Red Cross estimates that someone in the United States needs blood every two seconds. However, only around three percent of age-eligible people donate blood yearly. The percentage of adults who donated blood in the United States has not fluctuated much for the past two decades. In 2021, around 15 percent of U.S. adults donated blood, the same share reported in the year 2003.

This statistic illustrates the distribution of blood groups in the French population, according to the Rhesus system. It shows that less than 1 percent of French people had the blood group AB negative.

Immunohematology Market size was valued at USD 3.91 Billion in 2023 and is projected to reach USD 8.15 Billion by 2030, growing at a CAGR of 12.1% during the forecast period 2024-2030.

Global Immunohematology Market Drivers

The market drivers for the Immunohematology Market can be influenced by various factors. These may include:

Growing Need for Blood Transfusions: As the incidence of chronic illnesses, surgical procedures, and trauma cases rises, more blood transfusions become necessary, which fuels the market for immunohematology goods and services.Developments in Transfusion Medicine: The immunohematology market is expanding due to ongoing developments in transfusion medicine, which include enhanced compatibility testing, blood typing procedures, and blood storage strategies.
Growing Geriatric Population: As the world’s population ages, more people are becoming older and requiring blood transfusions to treat age-related illnesses, which is driving up demand for immunohematology products.
Growing Instances of Trauma and Accidents: The need for rapid blood transfusions due to accidents, crises, and trauma cases is a major factor driving the immunohematology market since it emphasizes the significance of accurate blood typing and compatibility testing.
Technological Developments in Immunohematology Testing: Automation, molecular testing, and point-of-care testing are examples of technological developments that have accelerated blood typing and compatibility testing, leading to increased market expansion.
Government attempts and Regulations: Tight regulatory rules requiring compatibility testing and blood screening, together with government attempts to improve blood safety and transfusion practices, are driving up demand for immunohematology services and supplies.
The adoption of immunohematology solutions is being driven by an increase in education and understanding among the general public and healthcare professionals about the significance of compatibility testing, blood type, and safe transfusion practices.
Growing Healthcare Expenditure: As healthcare facilities invest in cutting-edge blood banking technologies, rising healthcare spending in both developed and developing nations, along with a growing healthcare infrastructure, are anticipated to support the immunohematology market’s expansion.

Knops blood group antigens distribution among world populations.

The Fully Automated Blood Grouping System market has emerged as a crucial segment within the healthcare industry, primarily due to its role in enhancing transfusion safety and efficiency in blood banks and laboratories. These systems play a pivotal role in accurately determining blood types and compatibility, which

Snapshot img

Blood Bags Market Size 2024-2028

The blood bags market size is forecast to increase by USD 203.7 million at a CAGR of 8.1% between 2023 and 2028.

The market is experiencing significant growth due to several key drivers. The increasing number of hospitals and blood banks is a major factor fueling market growth. Moreover, growing awareness about the importance of blood donation and the need for safe blood transfusions is also contributing to market expansion. The market is growing rapidly as healthcare services continue to expand, ensuring a reliable supply of blood for transfusions and enhancing patient care in hospitals and emergency medical settings. However, challenges such as the risk of blood infections from pathogens like Pseudomonas and Yersinia, as well as the presence of endotoxins in infected blood, pose significant hurdles. To address these challenges, there is a growing demand for advanced blood bags with features such as perforated surfaces and component preparation to ensure the safety and efficacy of blood transfusions. The market is expected to grow steadily due to the large and aging population, which requires regular blood transfusions.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market is a significant segment of the biomedical industry, catering to the collection, storage, and transportation of whole blood products for various medical applications. This market encompasses various types of blood bags, including those used for venesection, paediatric recipients, and component preparation. During the blood collection process, it is crucial to maintain the sterility and safety of the blood bags to prevent bacterial contamination. Gram-negative bacteria, such as Pseudomonas and Yersinia, pose a significant threat due to their ability to produce endotoxins that can cause adverse reactions during transfusion. These reactions may include cardiorespiratory support requirements and the need for broad-spectrum antibiotics. Perforated blood bags are a common type used in component preparation. These bags facilitate the separation of components, such as red blood cells (RBCs), from the whole blood. However, the use of plasticizers in these bags has raised concerns regarding toxicity, including hepatomegaly and hepatocarcinogenicity. The peroxisomes in the liver play a crucial role in the ?-oxidation process, which helps eliminate these toxins.


Autologous blood, derived from the patient's own body, and homologous blood, obtained from a donor, are two primary types of blood used for transfusion. Anticoagulants are essential in preventing hemolysis, the destruction of RBCs, and air embolism during storage and transportation. Despite advancements in technology and stringent regulations, challenges persist in the blood bags market. These include minimizing the risk of bacterial contamination, ensuring the safety and efficacy of anticoagulants, and addressing the potential toxicity of plasticizers.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Collection bag
  Transfer bag


Geography

  North America

    Canada
    US


  Asia

    China
    Japan


  Europe

    Germany


  Rest of World (ROW)

By Type Insights

The collection bag segment is estimated to witness significant growth during the forecast period.

The market encompasses the production and distribution of blood collection bags, which play a vital role in the healthcare industry. These bags, including perforated and paediatric recipient types, are utilized during venesection procedures for efficient blood collection. Collection bags are essential in hospitals, blood banks, and healthcare facilities due to the increasing number of blood donation drives, heightened awareness of the significance of blood donation, and the growing prevalence of chronic diseases and surgical procedures necessitating regular blood transfusions. Blood bags are designed to maintain the sterility and integrity of the blood during the collection process. Equipped with multiple tubes and needles, they facilitate the efficient extraction of blood.

However, the risk of contamination from pathogens such as Pseudomonas and Yersinia, as well as endotoxins, necessitates stringent quality control measures during component preparation. This segment of the market has experienced consistent growth due to the increasing demand for blood transfusions. Blood bags are a crucial investment for healthcare providers, ensuring a reliable and safe blood supply for patients in need. The market for these essential medical devices is expected to continue expanding as the global population a

In 2018, it was estimated that high-income countries accounted for 40 percent of blood donations worldwide, although high-income countries represent just 16 percent of the world population. This statistic shows the distribution of blood donations worldwide compared to population distribution in 2018, by income group.

Snapshot img

Venous Blood Collection Market Size 2024-2028

The venous blood collection market size is forecast to increase by USD 470.6 million, at a CAGR of 4.5% between 2023 and 2028. The growth of the market is driven by several crucial factors. The increasing prevalence of cardiovascular diseases (CVDs) heightens the demand for advanced diagnostic and therapeutic devices designed to manage and treat heart conditions. Additionally, the increasing incidence of trauma and accidents leads to a greater need for emergency medical equipment and surgical interventions. This trend is further supported by the rising number of surgical procedures globally, which requires a wide range of medical devices for various types of surgeries. These factors collectively contribute to market expansion by driving innovation and investment in medical technologies that address urgent healthcare needs and enhance patient outcomes worldwide.

What will be the Size of the Market During the Forecast Period?

For More Highlights About this Report, Request Free Sample

Market Dynamic and Customer Landscape

The market is witnessing significant growth due to the increasing prevalence of infectious diseases such as hepatitis B, hepatitis C, human immunodeficiency virus (HIV), malaria, and blood cancer. Hospital and Clinics, Blood Donation Center, Diagnostic Center, and Independent Laboratories are the major end-users of venous blood collection tubes and holders. The market is driven by the rising number of road accidents leading to trauma cases and the need for immediate blood transfusion. Laboratory hematologists play a crucial role in the collection and analysis of venous blood samples. The market is segmented based on the type of tubes and holders, including plain, EDTA, heparin, and other types. The market is also expected to grow due to the development of vaccine candidates and molecular diagnostic tests using venous blood samples. Product contamination is a major challenge in the market, and stringent regulations are being implemented to ensure the safety and quality of blood collection tubes and holders. Hydroxychloroquine and other molecules are used in the production of blood collection tubes to prevent contamination and ensure the stability of the samples. The aging population is another factor driving the growth of the market due to the increasing prevalence of chronic diseases and the need for regular monitoring and diagnosis.

Key Market Driver

Increasing prevalence of CVDs is notably driving market growth. Venous blood collection plays a crucial role in diagnosing various chronic and infectious illness conditions, including syphilis, brucellosis, and lifestyle-related diseases, such as cancer and cardiovascular diseases. The global prevalence of these diseases is on the rise, with the World Health Organization reporting an estimated 19.3 million new cancer cases in 2020. Furthermore, the incidence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and lung cancer, is increasing globally. This growing health concern necessitates an increase in diagnostic tests, leading to a higher demand for venous blood collection.

Additionally, the aging population, particularly the geriatric population, requires frequent blood tests due to the higher prevalence of diseases in this demographic. Public-private funding and healthcare policies are also driving the growth of the market, with investments in liquid biopsy tests, vaccine candidates, and molecular-based diagnostics. Surgical procedures and blood donation also contribute to the demand for venous blood collection. Tubes and holders are essential components of the venous blood collection process, ensuring the accuracy and safety of the tests. Hydroxychloroquine and other medications may also require venous blood collection for monitoring and dosage adjustments. Thus, such factors are driving the growth of the market during the forecast period.

Key Market Trends

Growing number of strategic developments is the key trend in the market. The market has witnessed an increasing number of new product launches to cater to the growing demand for advanced diagnostic tests. In February 2022, the Food and Drug Administration (FDA) granted regulatory approval to Roche's Foundation Medicine for a circulatory tumor DNA (CTDNA) assay in plasma, making it the latest FDA breakthrough designation. This test, which identifies molecular residual disease (MRD) in primary cancer patients after curative treatment, is crucial as certain medications eradicate tumors but leave residual illness. The MRD status can help determine if additional therapy is necessary and the risk of recurrence.

Additionally, the market is witnessing significant growth due to the rising prevalence of lifestyle-related diseases, such as diabetes and cardiovascular diseases, in the aging population. Public-private funding and healthcare policies are a

Blood Tubing Set Sales Market is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecasted period i.e. 2024 to 2031.

Global Blood Tubing Set Sales Market Drivers

Growing Prevalence of Chronic Diseases: The need for blood tubing sets, which are used in hemodialysis and other medical operations, is driven by the growing prevalence of chronic diseases such diabetes, cardiovascular problems, and renal disease. The need for blood tubing sets for dialysis treatment and blood transfusions rises along with the global incidence of these illnesses, driving market expansion.

Growing Aging Population: Increasingly Elderly Population The elderly population is more vulnerable to age-related illnesses and chronic disorders, which call for medical treatments like dialysis. The need for blood tubing systems to support dialysis treatments and other medical operations among senior patients is rising due to the demographic change in several nations towards older age groups, which is propelling market expansion.

Innovations in Blood Tubing Set Technology: Medical device technology is always evolving, resulting in the creation of novel blood tubing sets that offer enhanced performance attributes, safety features, and patient comfort. Improved features including integrated safety systems, anti-kink designs, and biocompatible materials encourage the use of more recent blood tubing sets and propel market growth.

Growing Number of Dialysis Centres: Blood tubing sets are sold as a result of the opening and growth of dialysis clinics and centres to accommodate the rising demand for renal replacement treatment. In order to carry out hemodialysis treatments, dialysis centres need a regular supply of disposable consumables like blood tubing sets, which supports market growth and creates a stable demand for these items.

Increasing Costs of Healthcare: Purchasing medical equipment and supplies, such as blood tubing sets, is facilitated by rising healthcare spending by governments, commercial insurers, and private citizens. Adoption of sophisticated blood tubing sets is driven by investments in healthcare infrastructure, equipment improvements, and quality improvement activities, which also promote market expansion.

Increasing Knowledge of Bloodborne Illnesses: Increasing knowledge of bloodborne illnesses, including hepatitis, HIV/AIDS, and other infectious diseases, highlights the significance of utilising sterile, disposable medical equipment, such as blood tubing sets, to avoid cross-contamination and guarantee patient safety. Single-use blood tubing sets are in high demand due to stringent regulatory regulations and infection control standards, which is fueling the market’s expansion.

Growth of Healthcare Infrastructure and Access in Emerging countries: The availability of medical treatments and procedures, such as blood transfusions and hemodialysis, is boosted by the development of healthcare infrastructure and access in emerging countries. The demand for blood tubing sets for medical procedures rises as these regions’ healthcare systems get better and more accessible to underprivileged populations, which propels market expansion.

Growing Incidence of End-Stage Renal Disease (ESRD) and Acute Kidney Injury (AKI): The need for blood tubing sets, which are used in dialysis treatments, is fueled by the rising incidence of ESRD and AKI brought on by conditions like diabetes, hypertension, and lifestyle-related illnesses. Regular dialysis therapy is necessary for patients with AKI or ESRD to control their condition, which sustains market growth and generates steady demand for blood tubing sets.

Government Programmes to Expand Access to Healthcare: Medical device and consumable uptake, particularly blood tubing sets, is driven by government programmes aimed at lowering the burden of chronic diseases, increasing access to healthcare, and expanding insurance coverage. Expanding patient access to these vital medical procedures—dialysis and blood transfusions—through subsidies, reimbursement guidelines, and public health initiatives promotes market growth.

Laboratory Blood Sampling Tube Market Outlook

The global laboratory blood sampling tube market size is projected to grow significantly from USD 2.5 billion in 2023 to an estimated USD 3.8 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period. This growth is primarily driven by advancements in medical technologies and the increasing prevalence of chronic diseases requiring regular blood tests.

One of the primary growth factors for the laboratory blood sampling tube market is the increasing global burden of chronic and infectious diseases. Conditions such as diabetes, cardiovascular diseases, and various cancers necessitate regular blood testing for monitoring and management. This has led to a substantial rise in the demand for laboratory blood sampling tubes. Additionally, the ongoing COVID-19 pandemic has further amplified the need for frequent blood tests, thereby propelling the market forward. The continual development of healthcare infrastructure in emerging economies is also playing a crucial role in the marketÂ’s expansion.

The surge in the aging population worldwide is another major growth driver for the laboratory blood sampling tube market. As the elderly population is more susceptible to chronic illnesses and infections, the demand for diagnostic tests, including blood tests, is significantly higher in this demographic. Governments and healthcare organizations are increasingly focusing on improving healthcare services for the elderly, which is expected to boost the demand for blood sampling tubes. Furthermore, advancements in diagnostic technologies and the growing trend of preventive healthcare are positively influencing the market.

The continuous innovation in blood sampling tubes, such as the development of new materials and coatings to improve sample quality and shelf life, is also contributing to market growth. Manufacturers are focusing on producing tubes that can enhance the accuracy and reliability of diagnostic tests. Moreover, the increasing adoption of automated blood collection systems in laboratories and hospitals is likely to drive the demand for advanced blood sampling tubes. The integration of such technologies simplifies the blood collection process, reduces human error, and improves patient comfort, thereby fueling market growth.

The emergence of Blood Collection Tubes for Liquid Biopsy is revolutionizing the field of diagnostics, particularly in oncology. These tubes are designed to preserve the integrity of circulating tumor cells and cell-free DNA, which are crucial for non-invasive cancer diagnostics and monitoring. As the demand for personalized medicine grows, liquid biopsy is becoming an essential tool for early cancer detection and treatment monitoring. This advancement not only enhances the accuracy of diagnostic tests but also offers a less invasive alternative to traditional tissue biopsies, thereby improving patient comfort and compliance. The integration of liquid biopsy into routine clinical practice is expected to drive the demand for specialized blood collection tubes, further propelling the market growth.

From a regional perspective, North America is expected to dominate the laboratory blood sampling tube market due to its well-established healthcare infrastructure and high healthcare expenditure. Europe follows closely, driven by the increasing prevalence of chronic diseases and a robust healthcare system. The Asia Pacific region is projected to witness the highest growth rate during the forecast period, attributed to the expanding healthcare sector, rising medical tourism, and increasing investments in healthcare infrastructure. Latin America and the Middle East & Africa are also expected to experience steady growth, supported by improving healthcare facilities and growing awareness about early disease diagnosis and prevention.

Product Type Analysis

The laboratory blood sampling tube market is segmented by product type into serum separating tubes, EDTA tubes, plasma separation tubes, heparin tubes, coagulation tubes, and others. Serum separating tubes are widely used in clinical laboratories for their efficiency in separating serum from blood for various types of diagnostic tests. These tubes contain a special gel that facilitates quick and easy separation of serum, making them a preferred choice in many laboratories. The continual advancements in serum separator technology, aimed at improving sample quality and reducing hemolysis, are expected to drive the d

Blood Analysis System Market Outlook

The global blood analysis system market size was valued at approximately USD 6.5 billion in 2023 and is projected to reach around USD 11.2 billion by 2032, growing at a CAGR of 6.3% from 2024 to 2032. The primary growth factor driving this market is the increasing prevalence of chronic diseases like diabetes, cardiovascular diseases, and cancer, which require frequent and accurate blood testing for effective management and treatment.

One of the most significant growth factors of the blood analysis system market is the rising incidence of chronic and infectious diseases worldwide. The increasing burden of diseases such as diabetes, HIV/AIDS, hepatitis, and various cancers necessitates regular blood analysis for diagnosis, monitoring, and treatment. The aging global population further exacerbates this need, as older adults are more susceptible to chronic conditions that require frequent blood tests. Additionally, lifestyle-related diseases stemming from unhealthy diets, sedentary lifestyles, and obesity are on the rise, further driving the demand for reliable blood analysis systems.

Technological advancements in blood analysis systems are another critical growth factor. Modern systems are becoming increasingly sophisticated, offering higher accuracy, faster processing times, and more comprehensive testing capabilities. Innovations such as point-of-care testing devices, which allow for rapid and on-site blood analysis, are revolutionizing the market. These devices are particularly beneficial in emergency settings and remote areas where traditional laboratory facilities might not be available. Furthermore, advancements in automation and integration with digital health technologies are making blood analysis more efficient and accessible, contributing to market growth.

The growing emphasis on preventive healthcare is also propelling the blood analysis system market. Governments and healthcare organizations across the globe are increasingly focusing on early diagnosis and preventive measures to reduce the incidence and impact of diseases. Blood tests are a fundamental component of preventive healthcare, allowing for the early detection of potential health issues before they become severe. This proactive approach to health management is driving the adoption of blood analysis systems in various healthcare settings, including hospitals, diagnostic laboratories, and research institutes.

From a regional perspective, North America holds the largest market share in the blood analysis system market, driven by the high prevalence of chronic diseases, advanced healthcare infrastructure, and significant investments in healthcare research. However, the Asia Pacific region is expected to witness the fastest growth during the forecast period. Factors such as increasing healthcare expenditure, growing awareness about preventive healthcare, and the rising prevalence of chronic diseases are contributing to this growth. Additionally, favorable government initiatives and the expansion of healthcare facilities in emerging economies like China and India are boosting the demand for blood analysis systems in the region.

Product Type Analysis

The blood analysis system market is segmented into instruments, consumables, and software. Instruments include a wide range of devices used for blood testing, such as hematology analyzers, blood gas analyzers, and coagulation analyzers. These instruments are essential for conducting various types of blood tests, providing critical data for diagnosing and monitoring diseases. The demand for advanced and automated instruments is increasing, driven by the need for higher accuracy and efficiency in blood testing procedures. Technological advancements in these instruments, such as the integration of artificial intelligence and machine learning algorithms, are enhancing their capabilities and driving market growth.

Consumables, which include reagents, test strips, and other disposable items used in blood analysis, represent a significant segment of the market. These consumables are essential for the day-to-day operations of blood analysis systems, and their recurring nature ensures a steady demand. The increasing number of blood tests conducted globally, driven by the rising prevalence of chronic diseases and the growing focus on preventive healthcare, is boosting the demand for consumables. Furthermore, innovations in consumable products, such as the development of more accurate and sensitive reagents, are contributing to market growth.

The software segment of the blood analysis syst

Global Plastic Blood Collection Tubes Market size was valued at USD 2.10 Billion in 2023 and is projected to reach USD 3.56 Billion by 2031, growing at a CAGR of 6.85 % from 2024 to 2031.

Plastic blood collection tubes are medical devices used to collect, store, and transport blood samples in healthcare settings. They are typically composed of polyethylene or other biocompatible plastics and come in a variety of sizes and designs to meet varying sample amounts and testing needs.
Plastic blood collection tubes are widely used in clinical laboratories, hospitals, blood banks, and diagnostic centers for a variety of diagnostic procedures, including regular blood chemistry, hematology, serology, and infectious disease screening.
The future of plastic blood collection tubes looks optimistic, because of advances in material science, additive formulations, and manufacturing processes that drive innovation. Enhanced tube designs, enhanced closure mechanisms, and the incorporation of smart technologies are expected to improve sample stability, streamline workflow efficiency, and increase patient safety.
Furthermore, the growing emphasis on sustainability and environmental responsibility may result in the development of eco-friendly materials and recycling programs in the plastic blood collection tubes market.

Key Market Drivers

Growing Prevalence of Chronic Diseases: The rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer increases the demand for diagnostic testing, especially blood tests. Blood collection tubes are critical equipment for gathering and storing blood samples for laboratory examination, driving market growth.
Rapidly Growing Geriatric Population: The aging global population is predisposed to a variety of health issues that necessitate regular monitoring and diagnostic testing. As the older population grows, there is an increased demand for blood collection tubes for diagnostic purposes, which contributes to market growth.
Advancements is Healthcare Infrastructure: Increasing technological breakthroughs and improvements in healthcare infrastructure around the world have resulted in increased availability of diagnostic services. Hospitals, clinics, and diagnostic laboratories are becoming outfitted with contemporary facilities and equipment, including blood collection tubes, which are fueling market expansion.
Increasing Awareness of Preventive Healthcare: Increased awareness of preventive healthcare measures and early disease detection motivates people to get regular health screenings and diagnostic tests. Blood tests are important in preventative healthcare, which increases the demand for blood collection tubes.

The size and share of the market is categorized based on Type (Red Blood Cell Collection, Processing, Distribution Services, Blood Plasma Collection, Processing, Distribution Services, Organ Bank Services, Tissue Bank Services, Health Screening Services, All Other Human Blood Services, Reproductive and Stem Cell Bank Services) and Application (Hospitals, Diagnostic Canters, Blood Banks, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

Market Overview: The global blood processing devices market is estimated to reach $ million in 2025, exhibiting a CAGR of X% from 2025 to 2033. The increasing prevalence of chronic diseases, advancements in blood transfusion techniques, and growing demand for safe and efficient blood transfusion procedures drive market growth. The market segments include application (hospitals, blood banks) and type (centrifuge, blood cell processors, blood bank freezers and refrigerators, blood grouping analyzers). Market Dynamics: The market is propelled by factors such as rising blood transfusions, increasing awareness of blood-related diseases, and technological innovations. The availability of advanced devices for plasmapheresis, cell separation, and blood grouping enhances the efficiency of blood processing. However, the high cost of equipment and the stringent regulatory requirements present challenges to market growth. Key players include Haemonetics, Fresenius, Terumo, B. Braun Melsungen, and Macopharma. The Asia-Pacific region is expected to witness significant growth due to the increasing healthcare expenditure and the large population base. The global blood processing devices market is projected to witness a substantial growth from 2023 to 2030. The market is expected to generate revenue of over USD 25 billion by 2030. Considerable advancements in healthcare technology, escalating patient population suffering from chronic diseases, and the increasing need for blood transfusions drive the market growth.

This statistic shows the prevalence of raised blood pressure worldwide in 2014, by income group and gender. In that year, almost 28 percent of all males aged 18 years and over from low income households worldwide had raised blood pressure.

Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population.